Alternatives to BiotaX

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-driven drug discovery platform accelerating breakthrough scientific research.

AI-powered spatial biology platform for precision medicine and drug development.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Tech.Bio company advancing mRNA discovery with AI and its mRNA Lightning platform.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.